Association of point‐of‐care testing for sST2 with clinical outcomes in patients hospitalized with heart failure Article Swipe
Yuyi Chen
,
Jingyuan Guan
,
Qi Chen
,
Yihang Wu
,
Jing Wang
,
Xuemei Zhao
,
Xinqing Li
,
Chunhui He
,
Jian Zhang
,
Yuhui Zhang
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1002/ehf2.14860
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1002/ehf2.14860
Aims This study aimed to investigate the association of soluble suppression of tumorigenicity‐2 (sST2) measured by point‐of‐care testing assay with clinical outcomes in patients hospitalized with heart failure after adjusting for other predictors including N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) and high‐sensitivity cardiac troponin T (hs‐cTnT). Methods A total of 1726 consecutive patients hospitalized with heart failure from July 2015 to December 2021 were enrolled. Baseline serum sST2 concentrations were measured by immunofluorescence assay. Primary endpoint event was the composite of all‐cause death, heart transplantation, or left ventricular assist device. Results During the median follow‐up duration of 682 days, 434 patients (25.1%) suffered from primary endpoint events. Baseline sST2 remained an independent predictor of the primary endpoint event in patients hospitalized with heart failure after adjusting for other predictors including NT‐proBNP and hs‐cTnT [per log (unit) increase, adjusted hazard ratio (HR) (95% confidence interval) (CI): 1.20 (1.09, 1.32), P < 0.001]. And baseline sST2 had a better prognostic value for patients with chronic decompensated heart failure [per log (unit) increase, adjusted HR (95% CI): 1.19 (1.07, 1.31)] than for those with acute new onset heart failure [per log (unit) increase, adjusted HR (95% CI): 1.28 (0.94, 1.75), P value for interaction <0.001], as well as a better prognostic value for patients with New York Heart Association (NYHA) functional class I–II [per log (unit) increase, adjusted HR (95% CI): 1.67 (1.11, 2.52)] than for those with NYHA functional class III‐IV [per log (unit) increase, adjusted HR (95% CI): 1.18 (1.07, 1.31), P value for interaction <0.001]. Baseline sST2 was also a good predictor of the primary endpoint event in patients hospitalized with heart failure at 1 month, 3 months, 1 year and 2 years (area under the curve: 0.789, 0.775, 0.736 and 0.733, respectively), and the best cut‐off values were 27.2 ng/ml, 27.1 ng/ml, 27.1 ng/ml and 25.1 ng/ml, respectively. Furthermore, baseline sST2 could provide additional prognostic value when added to baseline NT‐proBNP and hs‐cTnT (all P values <0.05). According to the category of elevated biomarkers (including NT‐proBNP, hs‐cTnT, and sST2), patients with three elevated biomarkers had a higher risk of the primary endpoint event compared with those with one or two elevated biomarkers (all P values <0.05). Conclusions Baseline sST2 remained an independent predictor of adverse events after adjusting for other predictors including NT‐proBNP and hs‐cTnT, particularly in patients with chronic decompensated heart failure and NYHA functional class I–II. And in the basis of baseline NT‐proBNP and hs‐cTnT, adding baseline sST2 could provide additional prognostic value for patients hospitalized with heart failure.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/ehf2.14860
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.14860
- OA Status
- gold
- Cited By
- 3
- References
- 28
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4398217454
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4398217454Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/ehf2.14860Digital Object Identifier
- Title
-
Association of point‐of‐care testing for sST2 with clinical outcomes in patients hospitalized with heart failureWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-05-21Full publication date if available
- Authors
-
Yuyi Chen, Jingyuan Guan, Qi Chen, Yihang Wu, Jing Wang, Xuemei Zhao, Xinqing Li, Chunhui He, Jian Zhang, Yuhui ZhangList of authors in order
- Landing page
-
https://doi.org/10.1002/ehf2.14860Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.14860Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.14860Direct OA link when available
- Concepts
-
Medicine, Heart failure, Hazard ratio, Internal medicine, Clinical endpoint, Cardiology, Natriuretic peptide, Confidence interval, Heart transplantation, Clinical trialTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
28Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4398217454 |
|---|---|
| doi | https://doi.org/10.1002/ehf2.14860 |
| ids.doi | https://doi.org/10.1002/ehf2.14860 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38773746 |
| ids.openalex | https://openalex.org/W4398217454 |
| fwci | 1.4360536 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000097 |
| mesh[1].descriptor_ui | D006333 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | blood |
| mesh[1].descriptor_name | Heart Failure |
| mesh[2].qualifier_ui | Q000175 |
| mesh[2].descriptor_ui | D006333 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | diagnosis |
| mesh[2].descriptor_name | Heart Failure |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D008297 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Male |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005260 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Female |
| mesh[5].qualifier_ui | Q000097 |
| mesh[5].descriptor_ui | D000072179 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | blood |
| mesh[5].descriptor_name | Interleukin-1 Receptor-Like 1 Protein |
| mesh[6].qualifier_ui | Q000097 |
| mesh[6].descriptor_ui | D015415 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | blood |
| mesh[6].descriptor_name | Biomarkers |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D008875 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Middle Aged |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D011379 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Prognosis |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006760 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Hospitalization |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D000067716 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Point-of-Care Testing |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D005500 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Follow-Up Studies |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000368 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Aged |
| mesh[13].qualifier_ui | Q000097 |
| mesh[13].descriptor_ui | D020097 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | blood |
| mesh[13].descriptor_name | Natriuretic Peptide, Brain |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D011446 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Prospective Studies |
| mesh[15].qualifier_ui | Q000097 |
| mesh[15].descriptor_ui | D010446 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | blood |
| mesh[15].descriptor_name | Peptide Fragments |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | Q000097 |
| mesh[17].descriptor_ui | D006333 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | blood |
| mesh[17].descriptor_name | Heart Failure |
| mesh[18].qualifier_ui | Q000175 |
| mesh[18].descriptor_ui | D006333 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | diagnosis |
| mesh[18].descriptor_name | Heart Failure |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D008297 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Male |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | Q000097 |
| mesh[21].descriptor_ui | D000072179 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | blood |
| mesh[21].descriptor_name | Interleukin-1 Receptor-Like 1 Protein |
| mesh[22].qualifier_ui | Q000097 |
| mesh[22].descriptor_ui | D015415 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | blood |
| mesh[22].descriptor_name | Biomarkers |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D008875 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Middle Aged |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D011379 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Prognosis |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D006760 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Hospitalization |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D000067716 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Point-of-Care Testing |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D005500 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Follow-Up Studies |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D000368 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Aged |
| mesh[29].qualifier_ui | Q000097 |
| mesh[29].descriptor_ui | D020097 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | blood |
| mesh[29].descriptor_name | Natriuretic Peptide, Brain |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D011446 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Prospective Studies |
| mesh[31].qualifier_ui | Q000097 |
| mesh[31].descriptor_ui | D010446 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | blood |
| mesh[31].descriptor_name | Peptide Fragments |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D006801 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Humans |
| mesh[33].qualifier_ui | Q000097 |
| mesh[33].descriptor_ui | D006333 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | blood |
| mesh[33].descriptor_name | Heart Failure |
| mesh[34].qualifier_ui | Q000175 |
| mesh[34].descriptor_ui | D006333 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | diagnosis |
| mesh[34].descriptor_name | Heart Failure |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008297 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Male |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D005260 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Female |
| mesh[37].qualifier_ui | Q000097 |
| mesh[37].descriptor_ui | D000072179 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | blood |
| mesh[37].descriptor_name | Interleukin-1 Receptor-Like 1 Protein |
| mesh[38].qualifier_ui | Q000097 |
| mesh[38].descriptor_ui | D015415 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | blood |
| mesh[38].descriptor_name | Biomarkers |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D008875 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Middle Aged |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D011379 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Prognosis |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D006760 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Hospitalization |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D000067716 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Point-of-Care Testing |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D005500 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Follow-Up Studies |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D000368 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Aged |
| mesh[45].qualifier_ui | Q000097 |
| mesh[45].descriptor_ui | D020097 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | blood |
| mesh[45].descriptor_name | Natriuretic Peptide, Brain |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D011446 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Prospective Studies |
| mesh[47].qualifier_ui | Q000097 |
| mesh[47].descriptor_ui | D010446 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | blood |
| mesh[47].descriptor_name | Peptide Fragments |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D006801 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Humans |
| mesh[49].qualifier_ui | Q000097 |
| mesh[49].descriptor_ui | D006333 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | blood |
| mesh[49].descriptor_name | Heart Failure |
| type | article |
| title | Association of point‐of‐care testing for sST2 with clinical outcomes in patients hospitalized with heart failure |
| biblio.issue | 5 |
| biblio.volume | 11 |
| biblio.last_page | 2868 |
| biblio.first_page | 2857 |
| grants[0].funder | https://openalex.org/F4320321001 |
| grants[0].award_id | 81873472 |
| grants[0].funder_display_name | National Natural Science Foundation of China |
| grants[1].funder | https://openalex.org/F4320335777 |
| grants[1].award_id | 2017YFC1308300 |
| grants[1].funder_display_name | National Key Research and Development Program of China |
| topics[0].id | https://openalex.org/T12528 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9984999895095825 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | IL-33, ST2, and ILC Pathways |
| topics[1].id | https://openalex.org/T10198 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9968000054359436 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Heart Failure Treatment and Management |
| topics[2].id | https://openalex.org/T10051 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.944100022315979 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2737 |
| topics[2].subfield.display_name | Physiology |
| topics[2].display_name | Asthma and respiratory diseases |
| funders[0].id | https://openalex.org/F4320321001 |
| funders[0].ror | https://ror.org/01h0zpd94 |
| funders[0].display_name | National Natural Science Foundation of China |
| funders[1].id | https://openalex.org/F4320335777 |
| funders[1].ror | |
| funders[1].display_name | National Key Research and Development Program of China |
| is_xpac | False |
| apc_list.value | 3150 |
| apc_list.currency | EUR |
| apc_list.value_usd | 3366 |
| apc_paid.value | 3150 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 3366 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9268961548805237 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2778198053 |
| concepts[1].level | 2 |
| concepts[1].score | 0.8576299548149109 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q181754 |
| concepts[1].display_name | Heart failure |
| concepts[2].id | https://openalex.org/C207103383 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7972919940948486 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3930246 |
| concepts[2].display_name | Hazard ratio |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.7865431308746338 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C203092338 |
| concepts[4].level | 3 |
| concepts[4].score | 0.7505193948745728 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[4].display_name | Clinical endpoint |
| concepts[5].id | https://openalex.org/C164705383 |
| concepts[5].level | 1 |
| concepts[5].score | 0.6566399931907654 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q10379 |
| concepts[5].display_name | Cardiology |
| concepts[6].id | https://openalex.org/C2775915353 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5928758382797241 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1571529 |
| concepts[6].display_name | Natriuretic peptide |
| concepts[7].id | https://openalex.org/C44249647 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5901657342910767 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[7].display_name | Confidence interval |
| concepts[8].id | https://openalex.org/C2778849806 |
| concepts[8].level | 3 |
| concepts[8].score | 0.5850589871406555 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q643396 |
| concepts[8].display_name | Heart transplantation |
| concepts[9].id | https://openalex.org/C535046627 |
| concepts[9].level | 2 |
| concepts[9].score | 0.20666226744651794 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[9].display_name | Clinical trial |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9268961548805237 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/heart-failure |
| keywords[1].score | 0.8576299548149109 |
| keywords[1].display_name | Heart failure |
| keywords[2].id | https://openalex.org/keywords/hazard-ratio |
| keywords[2].score | 0.7972919940948486 |
| keywords[2].display_name | Hazard ratio |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.7865431308746338 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/clinical-endpoint |
| keywords[4].score | 0.7505193948745728 |
| keywords[4].display_name | Clinical endpoint |
| keywords[5].id | https://openalex.org/keywords/cardiology |
| keywords[5].score | 0.6566399931907654 |
| keywords[5].display_name | Cardiology |
| keywords[6].id | https://openalex.org/keywords/natriuretic-peptide |
| keywords[6].score | 0.5928758382797241 |
| keywords[6].display_name | Natriuretic peptide |
| keywords[7].id | https://openalex.org/keywords/confidence-interval |
| keywords[7].score | 0.5901657342910767 |
| keywords[7].display_name | Confidence interval |
| keywords[8].id | https://openalex.org/keywords/heart-transplantation |
| keywords[8].score | 0.5850589871406555 |
| keywords[8].display_name | Heart transplantation |
| keywords[9].id | https://openalex.org/keywords/clinical-trial |
| keywords[9].score | 0.20666226744651794 |
| keywords[9].display_name | Clinical trial |
| language | en |
| locations[0].id | doi:10.1002/ehf2.14860 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764810254 |
| locations[0].source.issn | 2055-5822 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2055-5822 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | ESC Heart Failure |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.14860 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ESC Heart Failure |
| locations[0].landing_page_url | https://doi.org/10.1002/ehf2.14860 |
| locations[1].id | pmid:38773746 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | ESC heart failure |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38773746 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11424329 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | ESC Heart Fail |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11424329 |
| locations[3].id | pmh:oai:doaj.org/article:d53f1b96b0c44c45b7c99733086d43e4 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | ESC Heart Failure, Vol 11, Iss 5, Pp 2857-2868 (2024) |
| locations[3].landing_page_url | https://doaj.org/article/d53f1b96b0c44c45b7c99733086d43e4 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5063504780 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5702-7744 |
| authorships[0].author.display_name | Yuyi Chen |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yuyi Chen |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5044379201 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Jingyuan Guan |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[1].affiliations[0].raw_affiliation_string | Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China |
| authorships[1].institutions[0].id | https://openalex.org/I200296433 |
| authorships[1].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jingyuan Guan |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China |
| authorships[2].author.id | https://openalex.org/A5101761225 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0393-5296 |
| authorships[2].author.display_name | Qi Chen |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Chen Qi |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5101750344 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4862-7243 |
| authorships[3].author.display_name | Yihang Wu |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yihang Wu |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5100378677 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2410-5408 |
| authorships[4].author.display_name | Jing Wang |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jing Wang |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5101854498 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-0748-8777 |
| authorships[5].author.display_name | Xuemei Zhao |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Xuemei Zhao |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5041398080 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Xinqing Li |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Xinqing Li |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5111236429 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Chunhui He |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Chunhui He |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5100409969 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-5093-4325 |
| authorships[8].author.display_name | Jian Zhang |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Jian Zhang |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5100624915 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-5158-0645 |
| authorships[9].author.display_name | Yuhui Zhang |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Yuhui Zhang |
| authorships[9].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.14860 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Association of point‐of‐care testing for sST2 with clinical outcomes in patients hospitalized with heart failure |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T12528 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9984999895095825 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | IL-33, ST2, and ILC Pathways |
| related_works | https://openalex.org/W588655279, https://openalex.org/W2383994333, https://openalex.org/W642714463, https://openalex.org/W2099628268, https://openalex.org/W44894489, https://openalex.org/W1988816170, https://openalex.org/W2376061089, https://openalex.org/W3123931368, https://openalex.org/W3210148669, https://openalex.org/W4390268811 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1002/ehf2.14860 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764810254 |
| best_oa_location.source.issn | 2055-5822 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2055-5822 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | ESC Heart Failure |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.14860 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | ESC Heart Failure |
| best_oa_location.landing_page_url | https://doi.org/10.1002/ehf2.14860 |
| primary_location.id | doi:10.1002/ehf2.14860 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764810254 |
| primary_location.source.issn | 2055-5822 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2055-5822 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | ESC Heart Failure |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.14860 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ESC Heart Failure |
| primary_location.landing_page_url | https://doi.org/10.1002/ehf2.14860 |
| publication_date | 2024-05-21 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2970190413, https://openalex.org/W2888731088, https://openalex.org/W4292497465, https://openalex.org/W3193598686, https://openalex.org/W4220946720, https://openalex.org/W2898897954, https://openalex.org/W2766427323, https://openalex.org/W2766914668, https://openalex.org/W2944687799, https://openalex.org/W3016601805, https://openalex.org/W3000603141, https://openalex.org/W2996837806, https://openalex.org/W4316494510, https://openalex.org/W2158872147, https://openalex.org/W2066913822, https://openalex.org/W2586860778, https://openalex.org/W2003194320, https://openalex.org/W2030358406, https://openalex.org/W2800974384, https://openalex.org/W2023936900, https://openalex.org/W2024066381, https://openalex.org/W2785790358, https://openalex.org/W2912654919, https://openalex.org/W4398217454, https://openalex.org/W4225396975, https://openalex.org/W4211262347, https://openalex.org/W2902583447, https://openalex.org/W4229016368 |
| referenced_works_count | 28 |
| abstract_inverted_index.1 | 274, 278 |
| abstract_inverted_index.2 | 281 |
| abstract_inverted_index.3 | 276 |
| abstract_inverted_index.A | 47 |
| abstract_inverted_index.P | 148, 197, 250, 325, 364 |
| abstract_inverted_index.T | 44 |
| abstract_inverted_index.a | 155, 205, 259, 346 |
| abstract_inverted_index.HR | 171, 191, 225, 244 |
| abstract_inverted_index.an | 110, 371 |
| abstract_inverted_index.as | 202, 204 |
| abstract_inverted_index.at | 273 |
| abstract_inverted_index.by | 16, 71 |
| abstract_inverted_index.in | 23, 118, 267, 387, 400 |
| abstract_inverted_index.of | 9, 12, 49, 80, 96, 113, 262, 332, 349, 374, 403 |
| abstract_inverted_index.or | 85, 359 |
| abstract_inverted_index.to | 5, 60, 319, 329 |
| abstract_inverted_index.434 | 99 |
| abstract_inverted_index.682 | 97 |
| abstract_inverted_index.And | 151, 399 |
| abstract_inverted_index.New | 212 |
| abstract_inverted_index.and | 40, 131, 280, 290, 293, 305, 322, 338, 384, 394, 406 |
| abstract_inverted_index.for | 31, 126, 159, 178, 199, 209, 232, 252, 379, 416 |
| abstract_inverted_index.had | 154, 345 |
| abstract_inverted_index.log | 134, 167, 187, 221, 240 |
| abstract_inverted_index.new | 182 |
| abstract_inverted_index.one | 358 |
| abstract_inverted_index.the | 7, 78, 92, 114, 263, 285, 294, 330, 350, 401 |
| abstract_inverted_index.two | 360 |
| abstract_inverted_index.was | 77, 257 |
| abstract_inverted_index.< | 149 |
| abstract_inverted_index.(95% | 141, 172, 192, 226, 245 |
| abstract_inverted_index.(HR) | 140 |
| abstract_inverted_index.(all | 324, 363 |
| abstract_inverted_index.1.18 | 247 |
| abstract_inverted_index.1.19 | 174 |
| abstract_inverted_index.1.20 | 145 |
| abstract_inverted_index.1.28 | 194 |
| abstract_inverted_index.1.67 | 228 |
| abstract_inverted_index.1726 | 50 |
| abstract_inverted_index.2015 | 59 |
| abstract_inverted_index.2021 | 62 |
| abstract_inverted_index.25.1 | 306 |
| abstract_inverted_index.27.1 | 301, 303 |
| abstract_inverted_index.27.2 | 299 |
| abstract_inverted_index.Aims | 1 |
| abstract_inverted_index.CI): | 173, 193, 227, 246 |
| abstract_inverted_index.July | 58 |
| abstract_inverted_index.NYHA | 235, 395 |
| abstract_inverted_index.This | 2 |
| abstract_inverted_index.York | 213 |
| abstract_inverted_index.[per | 133, 166, 186, 220, 239 |
| abstract_inverted_index.also | 258 |
| abstract_inverted_index.best | 295 |
| abstract_inverted_index.from | 57, 103 |
| abstract_inverted_index.good | 260 |
| abstract_inverted_index.left | 86 |
| abstract_inverted_index.risk | 348 |
| abstract_inverted_index.sST2 | 67, 108, 153, 256, 311, 369, 410 |
| abstract_inverted_index.than | 177, 231 |
| abstract_inverted_index.well | 203 |
| abstract_inverted_index.were | 63, 69, 298 |
| abstract_inverted_index.when | 317 |
| abstract_inverted_index.with | 20, 26, 54, 121, 161, 180, 211, 234, 270, 341, 355, 357, 389, 419 |
| abstract_inverted_index.year | 279 |
| abstract_inverted_index.(CI): | 144 |
| abstract_inverted_index.(area | 283 |
| abstract_inverted_index.0.736 | 289 |
| abstract_inverted_index.Heart | 214 |
| abstract_inverted_index.acute | 181 |
| abstract_inverted_index.added | 318 |
| abstract_inverted_index.after | 29, 124, 377 |
| abstract_inverted_index.aimed | 4 |
| abstract_inverted_index.assay | 19 |
| abstract_inverted_index.basis | 402 |
| abstract_inverted_index.class | 218, 237, 397 |
| abstract_inverted_index.could | 312, 411 |
| abstract_inverted_index.days, | 98 |
| abstract_inverted_index.event | 76, 117, 266, 353 |
| abstract_inverted_index.heart | 27, 55, 83, 122, 164, 184, 271, 392, 420 |
| abstract_inverted_index.ng/ml | 304 |
| abstract_inverted_index.onset | 183 |
| abstract_inverted_index.other | 32, 127, 380 |
| abstract_inverted_index.ratio | 139 |
| abstract_inverted_index.serum | 66 |
| abstract_inverted_index.study | 3 |
| abstract_inverted_index.those | 179, 233, 356 |
| abstract_inverted_index.three | 342 |
| abstract_inverted_index.total | 48 |
| abstract_inverted_index.under | 284 |
| abstract_inverted_index.value | 158, 198, 208, 251, 316, 415 |
| abstract_inverted_index.years | 282 |
| abstract_inverted_index.(0.94, | 195 |
| abstract_inverted_index.(1.07, | 175, 248 |
| abstract_inverted_index.(1.09, | 146 |
| abstract_inverted_index.(1.11, | 229 |
| abstract_inverted_index.(NYHA) | 216 |
| abstract_inverted_index.(sST2) | 14 |
| abstract_inverted_index.(unit) | 135, 168, 188, 222, 241 |
| abstract_inverted_index.0.733, | 291 |
| abstract_inverted_index.0.775, | 288 |
| abstract_inverted_index.0.789, | 287 |
| abstract_inverted_index.1.31), | 249 |
| abstract_inverted_index.1.31)] | 176 |
| abstract_inverted_index.1.32), | 147 |
| abstract_inverted_index.1.75), | 196 |
| abstract_inverted_index.2.52)] | 230 |
| abstract_inverted_index.During | 91 |
| abstract_inverted_index.I–II | 219 |
| abstract_inverted_index.adding | 408 |
| abstract_inverted_index.assay. | 73 |
| abstract_inverted_index.assist | 88 |
| abstract_inverted_index.better | 156, 206 |
| abstract_inverted_index.curve: | 286 |
| abstract_inverted_index.death, | 82 |
| abstract_inverted_index.events | 376 |
| abstract_inverted_index.hazard | 138 |
| abstract_inverted_index.higher | 347 |
| abstract_inverted_index.median | 93 |
| abstract_inverted_index.month, | 275 |
| abstract_inverted_index.ng/ml, | 300, 302, 307 |
| abstract_inverted_index.sST2), | 339 |
| abstract_inverted_index.values | 297, 326, 365 |
| abstract_inverted_index.(25.1%) | 101 |
| abstract_inverted_index.0.001]. | 150 |
| abstract_inverted_index.I–II. | 398 |
| abstract_inverted_index.Methods | 46 |
| abstract_inverted_index.Primary | 74 |
| abstract_inverted_index.Results | 90 |
| abstract_inverted_index.adverse | 375 |
| abstract_inverted_index.cardiac | 42 |
| abstract_inverted_index.chronic | 162, 390 |
| abstract_inverted_index.device. | 89 |
| abstract_inverted_index.events. | 106 |
| abstract_inverted_index.failure | 28, 56, 123, 165, 185, 272, 393 |
| abstract_inverted_index.months, | 277 |
| abstract_inverted_index.peptide | 38 |
| abstract_inverted_index.primary | 104, 115, 264, 351 |
| abstract_inverted_index.provide | 313, 412 |
| abstract_inverted_index.soluble | 10 |
| abstract_inverted_index.testing | 18 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Baseline | 65, 107, 255, 368 |
| abstract_inverted_index.December | 61 |
| abstract_inverted_index.III‐IV | 238 |
| abstract_inverted_index.adjusted | 137, 170, 190, 224, 243 |
| abstract_inverted_index.baseline | 152, 310, 320, 404, 409 |
| abstract_inverted_index.category | 331 |
| abstract_inverted_index.clinical | 21 |
| abstract_inverted_index.compared | 354 |
| abstract_inverted_index.duration | 95 |
| abstract_inverted_index.elevated | 333, 343, 361 |
| abstract_inverted_index.endpoint | 75, 105, 116, 265, 352 |
| abstract_inverted_index.failure. | 421 |
| abstract_inverted_index.measured | 15, 70 |
| abstract_inverted_index.outcomes | 22 |
| abstract_inverted_index.patients | 24, 52, 100, 119, 160, 210, 268, 340, 388, 417 |
| abstract_inverted_index.remained | 109, 370 |
| abstract_inverted_index.suffered | 102 |
| abstract_inverted_index.troponin | 43 |
| abstract_inverted_index.According | 328 |
| abstract_inverted_index.adjusting | 30, 125, 378 |
| abstract_inverted_index.composite | 79 |
| abstract_inverted_index.cut‐off | 296 |
| abstract_inverted_index.enrolled. | 64 |
| abstract_inverted_index.hs‐cTnT | 132, 323 |
| abstract_inverted_index.including | 34, 129, 382 |
| abstract_inverted_index.increase, | 136, 169, 189, 223, 242 |
| abstract_inverted_index.interval) | 143 |
| abstract_inverted_index.predictor | 112, 261, 373 |
| abstract_inverted_index.<0.05). | 327, 366 |
| abstract_inverted_index.(including | 335 |
| abstract_inverted_index.additional | 314, 413 |
| abstract_inverted_index.biomarkers | 334, 344, 362 |
| abstract_inverted_index.confidence | 142 |
| abstract_inverted_index.functional | 217, 236, 396 |
| abstract_inverted_index.hs‐cTnT, | 337, 385, 407 |
| abstract_inverted_index.predictors | 33, 128, 381 |
| abstract_inverted_index.prognostic | 157, 207, 315, 414 |
| abstract_inverted_index.<0.001], | 201 |
| abstract_inverted_index.<0.001]. | 254 |
| abstract_inverted_index.Association | 215 |
| abstract_inverted_index.Conclusions | 367 |
| abstract_inverted_index.NT‐proBNP | 130, 321, 383, 405 |
| abstract_inverted_index.all‐cause | 81 |
| abstract_inverted_index.association | 8 |
| abstract_inverted_index.consecutive | 51 |
| abstract_inverted_index.follow‐up | 94 |
| abstract_inverted_index.independent | 111, 372 |
| abstract_inverted_index.interaction | 200, 253 |
| abstract_inverted_index.investigate | 6 |
| abstract_inverted_index.natriuretic | 37 |
| abstract_inverted_index.suppression | 11 |
| abstract_inverted_index.ventricular | 87 |
| abstract_inverted_index.(hs‐cTnT). | 45 |
| abstract_inverted_index.Furthermore, | 309 |
| abstract_inverted_index.NT‐proBNP, | 336 |
| abstract_inverted_index.N‐terminal | 35 |
| abstract_inverted_index.hospitalized | 25, 53, 120, 269, 418 |
| abstract_inverted_index.particularly | 386 |
| abstract_inverted_index.(NT‐proBNP) | 39 |
| abstract_inverted_index.decompensated | 163, 391 |
| abstract_inverted_index.respectively. | 308 |
| abstract_inverted_index.concentrations | 68 |
| abstract_inverted_index.pro‐B‐type | 36 |
| abstract_inverted_index.respectively), | 292 |
| abstract_inverted_index.transplantation, | 84 |
| abstract_inverted_index.point‐of‐care | 17 |
| abstract_inverted_index.high‐sensitivity | 41 |
| abstract_inverted_index.immunofluorescence | 72 |
| abstract_inverted_index.tumorigenicity‐2 | 13 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.7500099 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |